Dergiler / Molecular Imaging and Radionuclide Therapy / 2021 / Cilt: 30 - Sayı: 3

Evaluation of the Histopathological Features of Early-stage Invasive Ductal Breast Carcinoma by 18Fluoride-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Flor-florodeoksiglukoz Pozitron Emisyon Tomografi/Bilgisayarlı Tomografi ile Erken Evre İnvaziv Duktal Meme Karsinomunun Histopatolojik Özelliklerinin Değerlendirilmes

Sayfa
11–18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This study suggests that 18F-FDG PET/CT may provide prognostic information in patients with early-stage IDBC.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study investigates the relationship between 18fluoride-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) parameters and histopathological features in patients with early-stage invasive ductal breast carcinoma (IDBC).
📊
Temel Bulgular & Veri:Methods: Patients with early-stage IDBC who underwent 18F-FDG PET/CT scan for staging were included in this retrospective study.
💡
Sonuç & Katkı:This study suggests that 18F-FDG PET/CT may provide prognostic information in patients with early-stage IDBC.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: This study investigates the relationship between 18fluoride-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) parameters and histopathological features in patients with early-stage invasive ductal breast carcinoma (IDBC). Methods: Patients with early-stage IDBC who underwent 18F-FDG PET/CT scan for staging were included in this retrospective study. The status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2, Ki-67 proliferative index, and grades of tumors were recorded. The conventional metabolic parameters [maximum standard uptake value (SUVmax) and average standard uptake value] and volume-based parameters [metabolic tumor volume (MTV) and total lesion glycolysis] of the primary tumor were obtained from the 18F-FDG PET/CT images. The associations and correlations between the 18F-FDG PET/CT parameters and histopathological features were assessed. Results: One hundred forty-three patients were included. 18F-FDG PET/CT parameters, other than MTV, were significantly associated with the ER and PR status and Ki-67 index, while T-staging was significantly associated with all 18F-FDG PET/CT parameters. In the axillary lymph node (ALN) involvement, no significant difference was found in the 18F-FDG PET/CT parameters. In terms of the pathological stage, a significant difference was found in all 18F-FDG PET/CT parameters. 18F-FDG PET/CT parameters, other than MTV, were significantly higher in non-luminal breast tumors than luminal tumors and in high-grade tumors than low-grade ones. Triple-negative tumors had the highest 18F-FDG PET/CT parameter, but the difference was insignificant for MTV. The SUVmax had the strongest correlation with Ki-67 proliferative index. Conclusion: Tumors with aggressive histopathological features had higher 18F-FDG PET/CT parameter values. This study suggests that 18F-FDG PET/CT may provide prognostic information in patients with early-stage IDBC.

Abstract

Amaç: Bu çalışmada, erken evre invaziv duktal meme karsinomunun histopatolojik özellikleri ile 18florür-florodeoksiglukoz (18F-FDG) pozitron emisyon tomografi/bilgisayarlı tomografi (PET/BT) parametreleri arasındaki ilişki incelenmiştir. Yöntem: Bu retrospektif çalışmaya evreleme için 18F-FDG PET/BT taraması yapılan erken evre invaziv duktal meme karsinomlu hastalar dahil edildi. Primer tümörün östrojen reseptör (ER), progesteron reseptör (PR) durumları ile insan epidermal büyüme faktörü reseptörü-2 ekspresyon durumu, Ki-67 proliferasyon indeksi ve histolojik dereceleri kaydedildi. Primer tümörün geleneksel metabolik parametreleri [maksimum standart alım değeri (SUVmaks), ortalama standart alım değeri] ve hacim bazlı parametreler [metabolik tümör hacmi (MTV) ve toplam lezyon glikoliz] 18F-FDG PET/BT görüntülerinden elde edildi. 18F-FDG PET/BT parametreleri ile histopatolojik özellikler arasındaki ilişki ve korelasyon değerlendirildi. Bulgular: Çalışmaya toplam 143 hasta dahil edildi. MTV dışındaki 18F-FDG PET/BT parametreleri, ER-PR durumu ve Ki-67 indeksi grubu ile anlamlı şekilde farklıydı. Öte yandan, T-evreleme ile tüm 18F-FDG PET/BT parametreleri arasında ileri düzeyde farklılık bulundu. Aksiller lenf nodu tutulumu durumunda 18F-FDG PET/BT parametreleri arasında anlamlı bir fark bulunmadı. Patolojik evre açısından tüm 18F-FDG PET/BT parametrelerinde anlamlı farklılık vardı. MTV dışındaki 18F-FDG PET/BT parametreleri non-luminal tümörlerinde luminal tümörlere göre ve yüksek grade tümörlerde düşük grade tümörlere göre anlamlı olarak daha yüksekti. Üçlü negatif tümörler en yüksek 18F-FDG PET/BT parametrelerine sahipti, ancak MTV için fark anlamlı değildi. Ki-67 proliferasyon indeksi ile en güçlü korelasyon SUVmaks değerinde görüldü. Sonuç: Agresif histopatolojik özellikleri olan tümörlerin 18F-FDG PET/BT parametreleri daha yüksekti. Bu sonuçlar, 18F-FDG PET/BT’nin erken evre invaziv duktal meme karsinomunda prognostik bilgi sağlayabileceğini düşündürmektedir.

🔖

Bu Makaleye Atıf Yap

EROL, M., ÖNNER, H., KARANİS, M. İ. E. (2021). Evaluation of the Histopathological Features of Early-stage Invasive Ductal Breast Carcinoma by 18Fluoride-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Imaging and Radionuclide Therapy, Cilt: 30 - Sayı: 3, 11–18. https://ajindex.com/articles/406072

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34
  2. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ; Panel members. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011;22:1736-1747
  3. Banerjee M, George J, Song EY, Roy A, Hryniuk W. Tree-based model for breast cancer prognostication. J Clin Oncol 2004;22:2567-2575
  4. Kwast AB, Voogd AC, Menke-Pluijmers MB, Linn SC, Sonke GS, Kiemeney LA, Siesling S. Prognostic factors for survival in metastatic breast cancer by hormone receptor status. Breast Cancer Res Treat 2014;145:503-511
  5. Caresia Aroztegui AP, García Vicente AM, Alvarez Ruiz S, Delgado Bolton RC, Orcajo Rincon J, Garcia Garzon JR, de Arcocha Torres M, Garcia-Velloso MJ; Oncology Task Force of the Spanish Society of Nuclear Medicine and Molecular Imaging. 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging. Tumour Biol 2017;39:1010428317728285
  6. Song BI, Hong CM, Lee HJ, Kang S, Jeong SY, Kim HW, Chae YS, Park JY, Lee SW, Ahn BC, Lee J. Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast Cancer. Nucl Med Mol Imaging 2011;45:117-124
  7. Kumar R, Chauhan A, Zhuang H, Chandra P, Schnall M, Alavi A. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat 2006;98:267-274
  8. Avril N, Menzel M, Dose J, Schelling M, Weber W, Jänicke F, Nathrath W, Schwaiger M. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med 2001;42:9-16
  9. Gil-Rendo A, Martínez-Regueira F, Zornoza G, García-Velloso MJ, Beorlegui C, Rodriguez-Spiteri N. Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer. Br J Surg 2009;96:166-170
  10. Groheux D, Giacchetti S, Moretti JL, Porcher R, Espié M, Lehmann-Che J, de Roquancourt A, Hamy AS, Cuvier C, Vercellino L, Hindié E. Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer. Eur J Nucl Med Mol Imaging 2011;38:426-435
  11. Koo HR, Park JS, Kang KW, Cho N, Chang JM, Bae MS, Kim WH, Lee SH, Kim MY, Kim JY, Seo M, Moon WK. 18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes. Eur Radiol 2014;24:610-618